BP003302: Human Peptide Ready HLA-A*11:01&B2M Monomer Protein with the C-His-Avi Tag
Source: The recombinant Human Peptide Ready HLA-A*11:01&B2M Monomer Protein, (amino acids Gly25-Thr305(HLA-A*11:01) & Ile21-Met119(B2M)) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Human Peptide Ready HLA-A*11:01&B2M Monomer protein with the C-His-Avi tag at 1 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Anti-HLA class I (W6/32) Antibody protein with the C-hFc tag with the EC50 of 3.4 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP003301: Biotinylated Human Peptide Ready HLA-A*11:01&B2M Monomer Protein with the C-His-Avi Tag
Source: The recombinant Biotinylated Human Peptide Ready HLA-A*11:01&B2M Monomer Protein, (amino acids Gly25-Thr305(HLA-A*11:01) & Ile21-Met119(B2M)) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Biotinlylated Human Peptide Ready HLA-A*11:01&B2M Monomer protein with the C-His-Avi tag at 0.5 ug/ml (100ul/Well) on streptavidin(5 ug/ml) precoated plate. Dose response curve for the recombinant Anti-HLA class I (W6/32) Antibody protein with the C-hFc tag with the EC50 of 2.8 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.